| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-05 |